Patents by Inventor Arthur L. Babson

Arthur L. Babson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4639242
    Abstract: The present invention relates generally to a unique vessel for separating a liquid from a solid phase in a single and convenient unit and, more particularly to a reaction vessel which may be used for conducting a number of different chemical and immunoassay methodologies.
    Type: Grant
    Filed: February 4, 1985
    Date of Patent: January 27, 1987
    Inventor: Arthur L. Babson
  • Patent number: 4559052
    Abstract: Disclosed is a uniquely simple, multiple use apparatus for the packaging of fluids, such as those reference fluids used for the calibration and standardization of blood gas instrumentation, which must not be exposed to air.
    Type: Grant
    Filed: February 17, 1984
    Date of Patent: December 17, 1985
    Inventor: Arthur L. Babson
  • Patent number: 4250041
    Abstract: This invention relates to a method for the removal of heparin from heparin-containing plasma test samples using an insoluble protamine reaction product, without adversely affecting subsequent testing of the plasma for clotting time. Protamine sulfate or a combination of protamine sulfate and serum albumin is cross-linked with glutaraldehyde to form an insoluble reaction product which is capable of adsorbing heparin. According to the method of this invention, excess amounts of either of the cross-linked protamine reaction products are added to blood plasma samples containing heparin and the mixture is agitated for a time sufficient to permit adsorption of substantially all heparin present. The insoluble protamine heparin complex formed is removed from the plasma along with any excess insoluble protamine reaction product. Aliquots of the heparin-free plasma may be subjected to coagulation tests in order to determine true clotting time.
    Type: Grant
    Filed: June 25, 1979
    Date of Patent: February 10, 1981
    Assignee: Warner-Lambert Company
    Inventors: Arthur L. Babson, James E. Turner
  • Patent number: 4205954
    Abstract: An immunoassay wherein the sample containing an immunologic substance is added to a suspension of particles coated with a second immunologic substance which is specific to the immunologic substance of the sample. The change in percentage of light transmission through the suspension undergoing the resulting agglutination is measured for a predetermined period of time and compared to a standard graph. The suspension is under constant agitation during the measurement.
    Type: Grant
    Filed: May 26, 1978
    Date of Patent: June 3, 1980
    Assignee: Warner-Lambert Company
    Inventor: Arthur L. Babson
  • Patent number: 4199502
    Abstract: This invention relates to a method for the removal of heparin from heparin-containing blood plasma test samples using an insoluble protamine reaction product, without adversely affecting subsequent testing of the plasma for clotting time. Protamine sulfate or a combination of protamine sulfate and serum albumin is cross-linked with glutaraldehyde to form an insoluble reaction product which is capable of adsorbing heparin. According to the method of this invention, excess amounts of either of the cross-linked protamine reaction products are added to blood plasma samples containing heparin and the mixture is agitated for a time sufficient to permit adsorption of substantially all heparin present. The insoluble protamine heparin complex formed is removed from the plasma along with any excess insoluble protamine reaction product. Aliquots of the heparin-free plasma may be subjected to coagulation tests in order to determine true clotting time.
    Type: Grant
    Filed: August 4, 1978
    Date of Patent: April 22, 1980
    Assignee: Warner-Lambert Company
    Inventors: Arthur L. Babson, James E. Turner
  • Patent number: 4152269
    Abstract: A blood collection assembly and closure therefor, for the collection, separation, isolation and storage of serum from blood. The closure is constructed of a cannula penetrable self-sealing elastomer and includes a thixotropic barrier material in a hollow central portion of the closure, so that the barrier material is sealed within the closure until blood has been collected in the collection container and centrifuged. Centrifugation forces the barrier material into a collecton container through the passageway created by the cannula.
    Type: Grant
    Filed: February 1, 1977
    Date of Patent: May 1, 1979
    Assignee: Warner-Lambert Company
    Inventor: Arthur L. Babson
  • Patent number: 4078552
    Abstract: The specific disclosure provides a device and method of making an incision of precise dimensions in a patient, preferably in the forearm, and determining exact bleeding from initial puncture of the skin until the flow of blood has ceased, i.e. hemostatis is complete. The device comprises a housing including a blade aperture at one end thereof adapted to be positioned in abutting engagement with the skin of the subject. A spring member and a blade member having at least one cutting edge are located in the housing. Means are also provided in the housing and is connected to the blade member for retracting the blade member inwardly from the blade aperture and against the bias of the spring member. Manually operable means are provided for releasably engaging the retracting means to maintain the blade member in a retracted position against the bias of the spring member until the device is ready for use.
    Type: Grant
    Filed: June 23, 1975
    Date of Patent: March 14, 1978
    Assignee: Warner-Lambert Company
    Inventors: Evan N. Chen, Arthur L. Babson
  • Patent number: 3957586
    Abstract: This invention relates to a system for the identification of bacteria which comprises a series of punched cards, each card representing a different biochemical test.
    Type: Grant
    Filed: May 8, 1975
    Date of Patent: May 18, 1976
    Assignee: Warner-Lambert Company
    Inventors: Arthur L. Babson, John S. Loder
  • Patent number: 3947378
    Abstract: The present invention relates to an improved process for the production of a deficient citrated plasma useful in the clinical laboratory as a control plasma for the testing of clotting function, and particularly, in patients who are on oral anticoagulant thereapy.
    Type: Grant
    Filed: December 23, 1974
    Date of Patent: March 30, 1976
    Assignee: Warner-Lambert Company
    Inventor: Arthur L. Babson